4AB:ETR
AbbVie Common Stock
241,50 €
arrow_downward
-1,27%(-3,10) 1D
8 қаз., 10:21:35 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
244,30 €
High
244,30 €
Low
241,50 €
Mkt. cap
479,52 млрд
Avg. vol.
672,00
Volume
264,00
52-wk high
244,60 €
52-wk low
162,85 €
No. of employees
57 мың
Open
244,30 €
High
244,30 €
Low
241,50 €
Mkt. cap
479,52 млрд
Avg. vol.
672,00
Volume
264,00
52-wk high
244,60 €
52-wk low
162,85 €
No. of employees
57 мың
News stories
From web sources and news partners
Benzinga
·
7 сағат бұрын
AbbVie Shares Rise After Hours on FDA Designations - AbbVie (NYSE:ABBV)
Investing.com
·
7 сағат бұрын
AbbVie options flow shows 4:1 call-to-put ratio as stock rises
Insider Monkey
·
13 сағат бұрын
Johnson & Johnson (JNJ) Is Becoming a Growth Stock. Does AbbVie (ABBV) Make JNJ Look Expensive?
Yahoo Finance
·
1 күн бұрын
AbbVie (ABBV) Pays Out More Than It Earns. How Long Can That Hold?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 мың
Founded2012 ж. 10 сәу.
HeadquartersNorth Chicago, Иллинойс, Америка Құрама Штаттары
Sector-
Websiteabbvie.com